- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 28, 2025 | 16.79M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $465.05M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $129.38M |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $8.15M |
| Short Term Debt | Q3 2025 · Jun 30, 2024 | $8.17M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $95.83M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $95.35M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $603.96M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $814.64M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $1.2B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $1.07B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $1.27B |
| Current Assets | Q3 2025 · Jun 30, 2024 | $1.22B |
| Total Assets | Q3 2025 · Mar 31, 2025 | $2.08B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $1.94B |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 17.43M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 17.3M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $13.6M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$58.46M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $813.41M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $770.44M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $726.17M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $1.95 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $4.82 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $2.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $4.92 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $66.58M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $197.99M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $17.14M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $49.42M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $51.36M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $126.24M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $136.1M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $376.14M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $269.31M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $681.71M |